Use of laryngeal muscle evoked potential recording for experimental vagus nerve stimulation

Abstract

The laryngeal muscle evoked potential (LMEP) is a neurophysiological outcome parameter that guarantees integrity of the nerve-electrode interface during experiments with vagus nerve stimulation (VNS). This paper discusses a large series of minimally invasive LMEP recordings in 46 female Lewis rats, implanted with a custom-made VNS electrode around the left cervical vagus nerve. After a 3-week recovery, LMEPs were recorded twice in each animal, with swapping the anode and cathode positions of the VNS electrode (polarity inversion). A VNS-induced LMEP was identified as the initial negative peak wave post-stimulation artifact, consistently recorded in all sweeps at a given stimulation output current. Latency was defined as the time from stimulation onset to this negative peak, and stimulation threshold as the lowest current showing a clear and reproducible LMEP. An LMEP response was shown by 37/46 animals (80.4%), with stimulation intensity threshold of 0.37 ± 0.27 mA and latency of 2.39 ± 0.45 ms. Administering the cathodic pulse phase first at the caudal electrode contact resulted in the shortest LMEP latencies (MWU: p = 0.049. 2.36 ± 0.43 ms vs. 2.41 ± 0.47 ms). Minimally invasive LMEP recording provides a feasible and reliable means for checking electrode functioning and correct implantation.

Keywords

laryngeal muscles / motor evoked potential / vagus nerve / vagus nerve stimulation

References

[1] Berthoud HR, Neuhuber WL. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci. 2000; 85: 1-17. www.elsevier.com/locate/autneu

[2] Mughrabi IT, Hickman J, Jayaprakash N, et al. Development and characterization of a chronic implant mouse model for vagus nerve stimulation. elife. 2021; 10: e61270.

[3] El Tahry R, Mollet L, Raedt R, et al. Repeated assessment of larynx compound muscle action potentials using a self-sizing cuff electrode around the vagus nerve in experimental rats. J Neurosci Methods. 2011; 198(2): 287-293.

[4] Dahlqvist Å, Carlsöö B, Hellström S. Fiber components of the recurrent laryngeal nerve of the rat: a study by light and electron microscopy. Anat Rec. 1982; 204(4): 365-370.

[5] Paxinos G. The Rat Nervous System. 3rd ed. Academic Press; 2004.

[6] Jotz P, Campos D, Rodrigues F, Xavier L. Histological asymmetry of the human recurrent laryngeal nerve. J Voice. 2011; 25: 8-14.

[7] Manzano GM, Giuliano LMP, Nóbrega JAM. A brief historical note on the classification of nerve fibers. Arq Neuropsiquiatr. 2008; 66(1): 117-119.

[8] Paintal AS. The conduction velocities of respiratory and cardiovascular afferent fibres in the vagus nerve. J Physiol. 1953; 121(2): 341-359.

[9] Kox M, van Eijk LT, Verhaak T, et al. Transvenous vagus nerve stimulation does not modulate the innate immune response during experimental human endotoxemia: a randomized controlled study. Arthritis Res Ther. 2015; 17(1): 150.

[10] Morris GL, Mueller WM, E-E TVNSSG. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. Neurology. 1999; 53(8): 1731.

[11] Sun P, Zhou K, Wang S, et al. Involvement of MAPK/NF-κB signaling in the activation of the cholinergic anti-inflammatory pathway in experimental colitis by chronic vagus nerve stimulation. PLoS One. 2013; 8: e69424.

[12] Meregnani J, Clarençon D, Vivier M, et al. Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton Neurosci. 2011; 160(1-2): 82-89.

[13] Kwan H, Garzoni L, Liu HL, et al. Vagus nerve stimulation for treatment of inflammation: systematic review of animal models and clinical studies. Bioelectron Med. 2016; 3: 1-6. http://www.ncbi.nlm.nih.gov/pubmed/29308423

[14] Bassi GS, Dias DPM, Franchin M, et al. Modulation of experimental arthritis by vagal sensory and central brain stimulation. Brain Behav Immun. 2017; 64: 330-343.

[15] Levine YA, Koopman FA, Faltys M, et al. Neurostimulation of the cholinergic anti-inflammatory pathway ameliorates disease in rat collagen-induced arthritis. PLoS One. 2014; 9(8): e104530.

[16] Koopman FA, Chavan SS, Miljko S, et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci USA. 2016; 113(29): 8284-8289.

[17] Werner MFP, Fraga D, Melo MCC, Souza GEP, Zampronio AR. Importance of the vagus nerve for fever and neutrophil migration induced by intraperitoneal LPS injection. Inflamm Res. 2003; 52(7): 291-296.

[18] Mollet L, Raedt R, Delbeke J, et al. Electrophysiological responses from vagus nerve stimulation in rats. Int J Neural Syst. 2013; 23(6): 1350027.

[19] Grimonprez A, Raedt R, De Taeye L, et al. A preclinical study of laryngeal motor-evoked potentials as a marker Vagus nerve activation. Int J Neural Syst. 2015; 25(8): 1550034.

[20] Larsen LE, Wadman WJ, Marinazzo D, et al. Vagus nerve stimulation applied with a rapid cycle has more profound influence on hippocampal electrophysiology than a standard cycle. Neurotherapeutics. 2016; 13(3): 592-602.

[21] Krahl SE, Senanayake SS, Handforth A. Destruction of peripheral C-fibers does not alter subsequent vagus nerve stimulation-induced seizure suppression in rats. Epilepsia. 2001; 42(5): 586-589.

[22] Bouckaert C, Raedt R, Larsen LE, et al. Laryngeal muscle-evoked potential recording as an indicator of vagal nerve fiber activation. Neuromodulation. 2022; 25(3): 461-470.

[23] Berger A, Carapancea E, Vespa S, et al. Vagus nerve stimulation-induced laryngeal motor evoked potentials for response prediction and intensity titration in drug-resistant epilepsy. Clin Neurophysiol. 2023; 147: 99-107.

[24] Bachmann H, Vandemoortele B, Vermeirssen V, et al. Vagus nerve stimulation enhances remyelination and decreases innate neuroinflammation in lysolecithin-induced demyelination. Brain Stimul. 2024; 17(3): 575-587.

[25] Ardesch JJ, Sikken JR, Veltink PH, Van Der Aa HE, Hageman G, Buschman HPJ. Vagus nerve stimulation for epilepsy activates the vocal folds maximally at therapeutic levels. Epilepsy Res. 2010; 89: 227-231.

[26] Vespa S, Stumpp L, Bouckaert C, et al. Vagus nerve stimulation-induced laryngeal motor evoked potentials: a possible biomarker of effective nerve activation. Front Neurosci. 2019; 13(Aug): 880.

[27] Freeberg MJ, Pinault GCJ, Tyler DJ, Triolo RJ, Ansari R. Chronic nerve health following implantation of femoral nerve cuff electrodes. J Neuroeng Rehabil. 2020; 17(1): 95.

[28] Sillay KA, Rutecki P, Cicora K, et al. Long-term measurement of impedance in chronically implanted depth and subdural electrodes during responsive neurostimulation in humans. Brain Stimul. 2013; 6(5): 718-726.

[29] Brocker DT, Grill WM. Principles of electrical stimulation of neural tissue. Handbook of Clinical Neurology. Vol 116. 3rd ed. Elsevier; 2013.

[30] Vučkovicvučkovic´* A, Rijkhoff NJM, Struijk JJ. Different pulse shapes to obtain small fiber selective activation by anodal blocking-a simulation study. IEEE Trans Biomed Eng. 2004; 51(5): 698-706.

[31] Ahmed U, Chang YC, Cracchiolo M, et al. Anodal block permits directional vagus nerve stimulation. Sci Rep. 2020; 10(1): 9221.

[32] Wee AS, Leis AA, Kuhn AR, Gilbert RW. Anodal block: can this occur during routine nerve conduction studies? Electromyogr Clin Neurophysiol. 2000; 40(7): 387-391.

[33] Chang YC, Cracchiolo M, Ahmed U, et al. Quantitative estimation of nerve fiber engagement by vagus nerve stimulation using physiological markers. Brain Stimul. 2020; 13(6): 1617-1630.

[34] Lee LY, Pisarri TE. Afferent properties and reflex functions of bronchopulmonary C-fibers. Respir Physiol. 2001; 125(1-2): 47-65.

[35] Woodbury DM, Woodbury JW. Effects of vagal stimulation on experimentally induced seizures in rats. Epilepsia. 1990; 31(s2): S7-S19.

[36] Ciotti F, John R, Katic Secerovic N, et al. Towards enhanced functionality of vagus neuroprostheses through in silico optimized stimulation. Nat Commun. 2024; 15(1): 6119.

[37] Dardai E, Heavner JE. Respiratory and cardiovascular effects of halothane, isoflurane and enflurane delivered via a Jackson-Rees breathing system in temperature controlled and uncontrolled rats. Methods Find Exp Clin Pharmacol. 1987; 9(11): 717-720. Accessed April 9, 2024. http://www.ncbi.nlm.nih.gov/pubmed/3448450

[38] Skovsted P, Sapthavichaikul S. The effects of isoflurane on arterial pressure, pulse rate, autonomic nervous activity, and barostatic reflexes. Can Anaesth Soc J. 1977; 24(3): 304-314.

[39] Brichant JF, Gunst SJ, Warner DO, Rehder K. Halothane, enflurane, and isoflurane depress the peripheral vagal motor pathway in isolated canine tracheal smooth muscle. Anesthesiology. 1991; 74(2): 325-332.

[40] Toader E, Cividjian A, Quintin L. Isoflurane suppresses central cardiac parasympathetic activity in rats: a pilot study. Minerva Anestesiol. 2011; 77(2): 142-146. Accessed April 9, 2024. http://www.ncbi.nlm.nih.gov/pubmed/21150849

[41] Yaghouby F, Shafer B, Vasudevan S. A rodent model for long-term vagus nerve stimulation experiments. Bioelectron Med (Lond). 2019; 2(2): 73-88.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.